================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): March 21, 2005
Altair Nanotechnologies Inc.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Canada 1-12497 33-1084375
------------------------------- ----------------- --------------------
(State or other jurisdiction of (Commission (IRS Employer
incorporation or organization) File Number) Identification No.)
204 Edison Way
Reno, NV 89502
---------------------------------------- ----------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code:
(801) 858-3750
---------------------------------------------------
N/A (Former name, former address, and formal fiscal year, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)
================================================================================
Item 7.01 Regulation FD Disclosure.
On March 4, 2005, Douglas Ellsworth, a Senior Vice President of the Altair
Nanotechnologies Inc. (the "Company"), filed with the SEC a Form 4 reporting,
among other things, the sale on March 2, 2005 of 28,600 Common Shares of the
Company in six (6) transactions subject to Section 16(b) under the Securities
Exchange Act and rules promulgated thereunder ("Section 16(b)"). Mr. Ellsworth
had previously filed with the SEC Forms 4 reporting the acquisition during
September 2004 of an aggregate of 7,500 Common Shares of the Company in
transactions subject to Section 16(b). The Company believes that the aggregate
profits, calculated in accordance with Section 16(b), from such purchases and
sales amount to $17,300 and are subject to the recovery provisions of Section
16(b). Accordingly, the Company demanded, and on March 21, 2005, received from
Mr. Ellsworth, a check in the amount of such profits and related materials.
In light of this event and separately, as a result of certain Form 4
filings required under Section 16(a) of the Securities Exchange Act that were
filed late, the Company is developing, an expects to promptly implement,
additional procedures with the goal of ensuring strict compliance by all of its
officers, directors and other persons subject to Section 16.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Altair Nanotechnologies Inc.
Dated: March 21, 2005 By /s/ Alan Gotcher
-------------------------------------
Alan Gotcher
Chief Executive Officer
3